November 17, 2021

What’s next for the business of longevity?

Investors including Larry Ellison, Jeff Bezos and Peter Thiel have spent billions on the business of living longer. The appeal is clear: more time to spend with loved ones, achieve goals and enjoy new experiences.

But the prospect of extending life also brings up a host of thorny societal, economic and philosophical issues. And though there’s general acceptance of certain fundamentals, like the importance of exercise and not smoking, there is still debate over how much life spans can be extended and exactly how to go about extending them.

David Sinclair, a Harvard biologist, has been studying aging and how to slow it for more than a decade. He is also a founder of at least 12 biotech start-ups and sits on the boards of several others.

DealBook spoke with Dr. Sinclair in an event last week about the business and science of extending life, with help from insightful questions offered by…

Read full article here: